Implications of the 2023–2024 MPXV clade I outbreak in the Democratic Republic of Congo to global public health

Angel N. Desai, Marion Koopmans, Ashley Otter, Martin P. Grobusch, Pikka Jokelainen, Barry Atkinson, Flavia Cunha, Sofia R. Valdoleiros, Veronica G. Preda, Francesco Maria Fusco, Chantal P. Rovers, Gilbert Greub, Antonino Di Caro, Lone Simonsen, Francine Ntoumi, Eskild Petersen*

*Corresponding author

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Abstract

Mpox, a zoonotic disease resulting from infection with monkeypox virus (MPXV), was previously considered endemic to Central and West Africa. However, an ongoing global outbreak of clade IIb (previously known as West African clade) MPXV, associated with human-to-human transmission primarily through sexual contact, has occurred since May 2022, with introduction of MPXV to regions and countries that had previously only reported sporadic imported cases [ 1, 2].
OriginalsprogEngelsk
TidsskriftClinical Microbiology and Infection
Vol/bind30
Udgave nummer9
Sider (fra-til)1092-1094
Antal sider3
ISSN1198-743X
DOI
StatusUdgivet - sep. 2024

Citer dette